Genentech started clinical trials on the drug in October 1996. During clinical trials, six patients suddenly started coughing up blood, and four of them later died.
Genentech initiated clinical trials on the medication in October 1996. Unfortunately, during these trials, six patients experienced severe bleeding, and tragically, four of them lost their lives.